Skip to main content
HR 757 108th Congress House Commerce Drug industry Electronic government information Fines (Penalties) Gifts Government Operations and Politics Government paperwork Government publicity Health Hospitals Internet Law Marketing Nursing homes Pharmacies Pharmacists Physicians Rebates Sales promotion Science, Technology, Communications

Drug Company Gift Disclosure Act

Introduced: February 13, 2003 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 26, 2003
Referred to the Subcommittee on Health.
Feb 13, 2003
Referred to the House Committee on Energy and Commerce.
Feb 13, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.
What's happening now February 26, 2003

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 948 Identical bill Drug Company Gift Disclosure Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 7
All 7 Democratic 6 Independent 1
D
Thompson, Bennie G.
Mississippi · May 6, 2004
 D
Schakowsky, Janice D.
Illinois · Feb 25, 2003
 D
Davis, Danny K.
Illinois · Feb 13, 2003
 D
DeLauro, Rosa L.
Connecticut · Feb 13, 2003
 D
Doggett, Lloyd
Texas · Feb 13, 2003
 D
Norton, Eleanor Holmes
District of Columbia · Feb 13, 2003
 I
Sanders, Bernard
Vermont · Feb 13, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 757: Drug Company Gift Disclosure Act. 108th Congress. Open America. https://openamerica.io/bill/108-HR-757/
MLA
"H.R. 757: Drug Company Gift Disclosure Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-757/.
Bluebook (legal)
H.R. 757, 108th Cong. (2026), https://openamerica.io/bill/108-HR-757/.
Markdown link
[H.R. 757: Drug Company Gift Disclosure Act](https://openamerica.io/bill/108-HR-757/)
Report a problem